K
Kura Oncology, Inc. (KURA)
NMS – Real vaqt narxi. Valyuta: USD
10.90
+0.54 (5.21%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
10.97
+0.07 (0.64%)
Bozordan keyin: Jun 26, 2026, 7:31 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
10.90
+0.54 (5.21%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
10.97
+0.07 (0.64%)
Bozordan keyin: Jun 26, 2026, 7:31 PM EDT
Kura Oncology, Inc. – bu klinik bosqichdagi biofarmatsevtika kompaniyasi bo'lib, u saratonni davolash uchun dori-darmonlarni ishlab chiqadi. Kompaniyaning birinchi tijoriy mahsuloti – bu KOMZIFTI (ziftomenib), kuchli, tanlab ta'sir qiluvchi, qaytariluvchan va og'iz orqali qabul qilinadigan kichik molekulali menin ingibitori; Darlifarnib, birinchi insonli FIT-001 sinovining 1-bosqichida tadqiq qilinayotgan preparat, u katta qattiq o'smalarda darlifarnibni boshqa maqsadli davolash usullari bilan birgalikda baholash uchun bir nechta guruhlarni o'z ichiga oladi; va KO-7246, keyingi avlod menin ingibitori, diabet va kardiyometabolik kasalliklarda qo'llash uchun, shuningdek, qattiq o'smalarda boshqa davolash usullari bilan birgalikda qo'llash uchun mo'ljallangan keyingi avlod menin ingibitorlari. Kompaniyaning shtab-kvartirasi San-Diego, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Francis J. Burrows Ph.D. | Chief Scientific Officer |
| Dr. Mollie Leoni M.D. | Chief Medical Officer |
| Dr. Roger Bakale Ph.D. | Senior Vice President of Manufacturing & Supply Chain |
| Dr. Troy Edward Wilson J.D., Ph.D. | Chairman, CEO & President |
| Mr. Brian T. Powl M.B.A., M.S. | Chief Commercial Officer |
| Mr. Greg Mann | Senior Vice President of Investor Relations & Corporate Affairs |
| Mr. Samir Vattompadam M.S. | Senior Vice President of Global Program Leadership |
| Mr. Thomas Doyle | Senior Vice President of Finance & Accounting |
| Ms. Kathleen Ford | Chief Operating Officer |
| Ms. Teresa Brophy Bair Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-04 | 8-K | kura-20260604.htm |
| 2026-05-26 | DEFA14A | d124531ddefa14a.htm |
| 2026-05-12 | 8-K | kura-20260512.htm |
| 2026-05-12 | 10-Q | kura-20260331.htm |
| 2026-04-10 | DEFA14A | kura_defa_14a_2026.htm |
| 2026-04-10 | DEF 14A | kura-20260410.htm |
| 2026-04-10 | ARS | kura_ars_2025.pdf |
| 2026-03-05 | 8-K | kura-20260305.htm |
| 2026-03-05 | 10-K | kura-20251231.htm |
| 2026-01-29 | 8-K | d18498d8k.htm |